Skip to main content

Table 1 Patient Characteristics

From: Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates

 

Emirati-Emiratis

Non-Emirati-Emiratis

Total number

33

33

Female/male

26/7

21/12

Systemic

4 (12.2%)

9 (27.3%)

Persistent Oligo JIA

10 (30.3%)

6 (18.2%)

Extended Oligo JIA

2 (6%)

1 (3%)

Poly JIA RF-ve

10 (30.3%)

10 (30.3%)

Poly JIA RF + ve

7 (21.2%)

5 (15.2%)

Enthesitis-related JIA

-

1 (3%)

Psoriatic

-

1 (3%)

Mean time from onset to first appointment with Ped Rheum (months)

9

12.4

Range: 1–48

Range: 1–96

Median time from onset to first appointment with Pediatric rheumatology

10 months

14 months

Oral steroids at diagnosis

31 (94%)

32 (97%)

>2 health professionals seen before pediatric rheumatologist

31 (94%)

25 (75.7%)

Referral to ophthalmology prior to pediatric rheumatology

7 (21.2%)

7 (21.2%)

Uveitis

3 (9%)

2 (6%)

MTX alone

10 (30.3%)

5 (15.2%)

Biologic + MTX treatment

10 (30.3%)

15 (45.5%)

Remission on treatment

12 (36.3%)

10 (30.3%)

Disability

1 blind (uveitis)

1 multiple joint deformities

  1. JIA Juvenile Idiopathic Arthritis, MTX Methotrexate